Fig. 1 · Structure

Documents & Downloads

OBI-992 drug-linker

Drug-Linker Conjugate

OBI-992 drug-linker is a targeted drug-linker conjugate featuring Exatecan, a potent topoisomerase I inhibitor, covalently linked to a proprietary linker. This compound demonstrates significant antitumor activity in preclinical mouse models, highlighting its potential in cancer therapy. OBI-992 is primarily employed in the synthesis of antibody-drug conjugates (ADCs) for innovative cancer treatment strategies.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer Adooq Bioscience
CAS Number 3039487-10-7
Applications Drug-Linker Conjugate
Formula C106H162FN9O37
Molecular Weight 2173.46
SMILES
O=C(C=CC1=O)N1CC2CCC(C(N[C@@H](CCC(N[C@H](C(N[C@H](C(NC3=CC=C(COC(N[C@H]4CCC5=C6C4=C7C(C(N8C7)=CC([C@](CC)(O)C(OC9)=O)=C9C8=O)=NC6=CC(F)=C5C)=O)C=C3)=O)C)=O)C(C)C)=O)C(NCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)=O)=O)CC2

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...